William Blair Investment Management LLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,225,933 shares of the company's stock after selling 244,283 shares during the period. Doximity makes up 0.8% of William Blair Investment Management LLC's holdings, making the stock its 18th biggest position. William Blair Investment Management LLC owned 3.33% of Doximity worth $332,403,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of DOCS. Global Retirement Partners LLC lifted its position in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. grew its stake in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares in the last quarter. Larson Financial Group LLC grew its stake in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares in the last quarter. Morse Asset Management Inc acquired a new stake in Doximity during the third quarter worth about $46,000. Finally, IFP Advisors Inc raised its position in shares of Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company's stock valued at $71,000 after buying an additional 1,029 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.
Insiders Place Their Bets
In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 37.40% of the company's stock.
Doximity Price Performance
Shares of Doximity stock traded up $0.24 during midday trading on Friday, reaching $63.01. The company had a trading volume of 4,032,344 shares, compared to its average volume of 1,880,535. The stock has a fifty day moving average price of $64.20 and a 200 day moving average price of $53.21. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The firm has a market cap of $11.76 billion, a PE ratio of 63.01, a P/E/G ratio of 4.10 and a beta of 1.34.
Analysts Set New Price Targets
DOCS has been the topic of several analyst reports. JPMorgan Chase & Co. increased their price target on shares of Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research report on Thursday, November 21st. Raymond James reiterated an "outperform" rating and issued a $83.00 price target (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Needham & Company LLC lifted their target price on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.22.
Check Out Our Latest Research Report on DOCS
Doximity Company Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
